Header Logo

Connection

CHADI CALARGE to Male

Back to Details
This is a "connection" page, showing publications CHADI CALARGE has written about Male.
CHADI CALARGE
Connection Strength
0.937
Male
  1. Iron Deficiency and Internalizing Symptoms Among Adolescents in the National Health and Nutrition Examination Survey. Nutrients. 2024 Oct 26; 16(21).
    View in: PubMed
    Score: 0.040
  2. Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Nov-Dec; 44(6):538-544.
    View in: PubMed
    Score: 0.040
  3. Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults. J Child Adolesc Psychopharmacol. 2023 09; 33(7):260-268.
    View in: PubMed
    Score: 0.037
  4. Sexual Functioning in Adolescents With Major Depressive Disorder: A Prospective Study. J Clin Psychiatry. 2021 10 05; 82(6).
    View in: PubMed
    Score: 0.032
  5. Gut microbiome in adolescent depression. J Affect Disord. 2021 09 01; 292:500-507.
    View in: PubMed
    Score: 0.032
  6. Predictors of depressive symptom trajectories in a prospective follow-up of late adolescents. Psychol Med. 2020 10; 50(13):2283-2288.
    View in: PubMed
    Score: 0.028
  7. First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome. BMC Psychiatry. 2019 04 24; 19(1):123.
    View in: PubMed
    Score: 0.027
  8. CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders. J Affect Disord. 2018 10 15; 239:247-252.
    View in: PubMed
    Score: 0.026
  9. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 10; 201:245-251.
    View in: PubMed
    Score: 0.026
  10. Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 2018 03; 28(2):145-150.
    View in: PubMed
    Score: 0.025
  11. The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults. J Bone Miner Res. 2017 Dec; 32(12):2367-2374.
    View in: PubMed
    Score: 0.024
  12. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. J Child Adolesc Psychopharmacol. 2017 Dec; 27(10):908-915.
    View in: PubMed
    Score: 0.024
  13. Comorbidity of Migraine, Major Depressive Disorder, and Generalized Anxiety Disorder in Adolescents and Young Adults. Int J Behav Med. 2017 08; 24(4):528-534.
    View in: PubMed
    Score: 0.024
  14. Polyunsaturated fatty acid composition and childhood adversity: Independent correlates of depressive symptom persistence. Psychiatry Res. 2017 10; 256:305-311.
    View in: PubMed
    Score: 0.024
  15. Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors. Pediatrics. 2017 Jul; 140(1).
    View in: PubMed
    Score: 0.024
  16. Bone Mass in Boys with Autism Spectrum Disorder. J Autism Dev Disord. 2017 06; 47(6):1749-1755.
    View in: PubMed
    Score: 0.024
  17. Sexual Functioning in Adolescents With Major Depressive Disorder. J Clin Psychiatry. 2016 07; 77(7):957-62.
    View in: PubMed
    Score: 0.022
  18. Toxoplasmosis Titers and past Suicide Attempts Among Older Adolescents Initiating SSRI Treatment. Arch Suicide Res. 2016 Oct-Dec; 20(4):605-13.
    View in: PubMed
    Score: 0.022
  19. Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth. J Child Adolesc Psychopharmacol. 2016 06; 26(5):471-7.
    View in: PubMed
    Score: 0.022
  20. Fat distribution and major depressive disorder in late adolescence. J Clin Psychiatry. 2016 Jan; 77(1):84-9.
    View in: PubMed
    Score: 0.022
  21. Iron homeostasis during risperidone treatment in children and adolescents. J Clin Psychiatry. 2015 Nov; 76(11):1500-5.
    View in: PubMed
    Score: 0.021
  22. Rapid adipose deposition with mood disorders. Ann Clin Psychiatry. 2015 Nov; 27(4):283-8.
    View in: PubMed
    Score: 0.021
  23. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry. 2015 Oct 06; 5:e652.
    View in: PubMed
    Score: 0.021
  24. Characterization of trabecular bone plate-rod microarchitecture using multirow detector CT and the tensor scale: Algorithms, validation, and applications to pilot human studies. Med Phys. 2015 Sep; 42(9):5410-25.
    View in: PubMed
    Score: 0.021
  25. Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys. J Clin Psychiatry. 2015 May; 76(5):607-13.
    View in: PubMed
    Score: 0.021
  26. The effect of psychostimulants on skeletal health in boys co-treated with risperidone. J Pediatr. 2015 Jun; 166(6):1449-54.e1.
    View in: PubMed
    Score: 0.021
  27. Major depressive disorder and bone mass in adolescents and young adults. J Bone Miner Res. 2014 Oct; 29(10):2230-7.
    View in: PubMed
    Score: 0.020
  28. Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment. J Child Adolesc Psychopharmacol. 2014 Apr; 24(3):120-9.
    View in: PubMed
    Score: 0.019
  29. Iron deficiency in pediatric patients in long-term risperidone treatment. J Child Adolesc Psychopharmacol. 2013 Mar; 23(2):101-9.
    View in: PubMed
    Score: 0.018
  30. Rate of weight gain and cardiometabolic abnormalities in children and adolescents. J Pediatr. 2012 Dec; 161(6):1010-5.
    View in: PubMed
    Score: 0.017
  31. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics. J Clin Psychiatry. 2011 Dec; 72(12):1685-90.
    View in: PubMed
    Score: 0.016
  32. Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):163-9.
    View in: PubMed
    Score: 0.016
  33. Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010 Dec; 20(6):495-502.
    View in: PubMed
    Score: 0.015
  34. Iron status in toddlerhood predicts sensitivity to psychostimulants in children. J Atten Disord. 2012 May; 16(4):295-303.
    View in: PubMed
    Score: 0.015
  35. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. J Clin Psychiatry. 2010 Mar; 71(3):338-47.
    View in: PubMed
    Score: 0.014
  36. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr Genet. 2009 Dec; 19(6):320-7.
    View in: PubMed
    Score: 0.014
  37. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics. 2009 May; 19(5):373-82.
    View in: PubMed
    Score: 0.014
  38. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):101-9.
    View in: PubMed
    Score: 0.014
  39. Electroconvulsive therapy in myasthenia gravis. Ann Clin Psychiatry. 2004 Oct-Dec; 16(4):225-7.
    View in: PubMed
    Score: 0.010
  40. Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child Psychiatrists. J Child Adolesc Psychopharmacol. 2024 10; 34(8):359-365.
    View in: PubMed
    Score: 0.010
  41. The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. J ECT. 2003 Dec; 19(4):221-5.
    View in: PubMed
    Score: 0.009
  42. Visualizing how one brain understands another: a PET study of theory of mind. Am J Psychiatry. 2003 Nov; 160(11):1954-64.
    View in: PubMed
    Score: 0.009
  43. Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors. J Child Adolesc Psychopharmacol. 2021 08; 31(6):439-444.
    View in: PubMed
    Score: 0.008
  44. One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. Neurotherapeutics. 2020 04; 17(2):743-753.
    View in: PubMed
    Score: 0.007
  45. Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence. J Clin Psychiatry. 2019 10 22; 80(6).
    View in: PubMed
    Score: 0.007
  46. Prolactin serum concentrations during aripiprazole treatment in youth. J Child Adolesc Psychopharmacol. 2013 May; 23(4):282-9.
    View in: PubMed
    Score: 0.005
  47. An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Ann Clin Psychiatry. 2011 Nov; 23(4):270-6.
    View in: PubMed
    Score: 0.004
  48. Theory of mind and schizophrenia: a positron emission tomography study of medication-free patients. Schizophr Bull. 2008 Jul; 34(4):708-19.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.